Questions About Cancer? 1-800-4-CANCER
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Featured Clinical Trials Supported by the National Cancer Institute

Today, thousands of cancer clinical trials are under way in the United States. Clinical trials answer vital research questions that lead to better screening, prevention, diagnosis, and treatment options for all cancers. This section highlights NCI-supported cancer trials and demonstrates the breadth of clinical cancer research supported by the Institute.

To find other cancer trials open to enrollment:

  • Call NCI's Cancer Information Service at 1-800-4-CANCER (1-800-422-6237) for information about trials all across the country. The call is toll-free and completely confidential.
  • Use the clinical trials search form to look online for trials listed on NCI's website. The form has a Help link for tips about searching for clinical trials.
  • For information about cancer trials taking place on the National Institutes of Health campus in Bethesda, Maryland, call NCI’s Clinical Trials Referral Office at 1-888-NCI-1937 (1-888-624-1937). The call is toll-free and completely confidential.
  • Targeted Treatment for Advanced Solid Tumors
    (Posted: 12/16/2008) - This clinical trial combines the drug dasatinib with the angiogenesis inhibitor bevacizumab for patients with metastatic or unresectable solid tumors.
  • New Drug for Patients with Advanced Thyroid Cancer
    (Posted: 11/18/2008) - In this phase II trial, researchers are studying the effects of treatment with 17-AAG, an antitumor antibiotic drug that targets a protein called HSP90, in patients with advanced medullary or differentiated thyroid cancer.
  • Comparing Surgical Treatment for Small NSCLC Tumors
    (Posted: 11/04/2008) - In this randomized phase III trial, patients with stage 1A non-small cell lung cancer tumors measuring 2 centimeters or less and located in the outer third of the lung are randomly assigned to sublobar resection (either wedge resection or segmentectomy) or lobectomy.
  • Comparison of Chemotherapy Combinations for Colon Cancer
    (Posted: 10/05/2004, Updated: 10/28/2008) - Researchers with this study are comparing combination chemotherapy and biological therapy regimens for stage III colon cancer following surgery.
  • Preventing Respiratory Infections in Patients with CLL
    (Posted: 10/21/2008) - This Featured Clinical Trial is a randomized, double-blind, placebo-controlled study to test the ability of CVT-E002 (COLD-fx) to reduce acute respiratory infections and the need for antibiotic treatment during the peak respiratory illness season (January through March) in people with chronic lymphocytic leukemia.
< Previous  11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31  Next >